奥达特罗

奥达特罗（CAS 868049-49-4）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.Breast Feeding; Lactation; Milk, Human; Anti-Asthmatic Agents; Beta Adrenergic Agonists; Bronchodilator Agents

同义词与商品名

OLODATEROL; 868049-49-4; BI-1744; BI 1744; VD2YSN1AFD; CHEBI:82700; DTXSID601024792; 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one; olodaterolum; RefChem:58865; R03AC19; DTXCID701513308; Olodaterol Free Base; 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one; Striverdi respimat (TN); Striverdi

GHS 危害分类

Reported hazard statements	H302 (100%), H319 (100%), H372 (50%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

公开数据库对它的描述

Olodaterol · CAS 868049-49-4 · C21H26N2O5. UNII VD2YSN1AFD.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。